NRTIs are Nucleoside analog Reverse-Transcriptase Inhibitors that block reverse transcriptase within HIV infected cells.  Reverse transcriptase is the process that converts RNA (single strand) to DNA (double strand) which enables the HIV virus to replicate.  The drugs interact with the enzymes that cause the conversion and stop it, so the HIV virus can not replicate.